OverviewChartNewsTraderScreen

Soc. Generale Knock-Out 4AB/  DE000SD050Q7  /

Frankfurt Zert./SG
17/05/2024  21:35:16 Chg.+0.190 Bid21:59:19 Ask21:59:19 Underlying Strike price Expiration date Option type
6.760EUR +2.89% 6.770
Bid Size: 4,000		 6.780
Ask Size: 4,000		 ABBVIE INC. D... 92.7981 - 31/12/2078 Call
GlobeNewswire 17/05 INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Merger between Cerev...
GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 16/05 Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
GlobeNewswire 14/05 CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough...
GlobeNewswire 14/05 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 14/05 In NCLA Amicus Win, and FTC Amicus Loss, Second Circuit Upholds Decision Dismissing Antitrust Suit
GlobeNewswire 13/05 Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire 11/05 SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LABP, DOMA, FXNC
GlobeNewswire 09/05 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 09/05 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 09/05 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
GlobeNewswire 09/05 Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...
GlobeNewswire 08/05 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 Alector Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 08/05 Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire 08/05 ArriVent BioPharma Reports First Quarter 2024 Financial Results
GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 07/05 Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 06/05 Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.
GlobeNewswire 02/05 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 02/05 Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer a...
GlobeNewswire 01/05 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...